Melatonin pretreatment modulates anti-inflammatory, antioxidant, YKL-40, and matrix metalloproteinases in endotoxemic rat lung tissue

Exp Biol Med (Maywood). 2022 Jun;247(12):1080-1089. doi: 10.1177/15353702221084933. Epub 2022 Apr 2.

Abstract

We aimed to investigate the effects of melatonin administered before and during endotoxemia on the lung tissue of rats, cytokine, YKL-40, matrix metalloproteinase (MMP) and inhibitor levels, oxidative stress parameters, and energy balance. Sepsis was induced with lipopolysaccharide (LPS), the cell wall molecule of gram negative bacteria. Rats were divided into four groups, Control, LPS (Escherichia coli O127:B8, 20 mg/kg), melatonin (10 mg/kg), and melatonin+LPS (M+LPS). After injections, lung tissues samples were taken for experimental analyses. YKL-40, thiobarbituric acid reactive substances (TBARS), glutathione reductase (GR), glutathione peroxidase (GSH-Px), superoxide dismutase (SOD) enzymes levels were measured, high-energy components were analyzed; tumor necrosis factor-alpha (TNF-α), MMP-2, YKL-40, MMP-9, myeloperoxidase (MPO), tissue inhibitors of matrix metalloproteinase (TIMP)-1, and interleukin (IL)-10 immunoreactivities were investigated. In LPS group, YKL-40, creatine phosphate (both, p < 0.05), SOD, GR, adenosine mono-phophate (AMP), adenosine tri-phosphate (ATP) (for all, p < 0.01) were significantly decreased, while TBARS and adenosine di-phosphate (ADP) levels were increased (p < 0.01, p < 0.05; respectively) compared to other groups. MMP-2 and -9, TIMP-1, TNF-α, IL-10, and MPO immunoreactivity were investigated in LPS group. On the contrary, in M+LPS group, MMP-9, TIMP-1 immunoreactivities were not found and IL-10 and MMP-2 immunoreactivities were found with little involvement. In M+LPS group, YKL-40, GR, AMP, ATP, creatine phosphate (for all, p < 0.05), and SOD (p < 0.01) levels were significantly increased and TBARS levels were decreased (p < 0.05). In our study, we suggest that melatonin exerts a protective and curative effect by reducing the matrix metalloproteinase levels responsible for tissue damage balance, stimulating the release of antioxidant enzymes, regulating cytokines and energy balance during endotoxemia.

Keywords: Melatonin; YKL-40; cytokines; lipopolysaccharide; matrix metalloproteinases; oxidative stress.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine
  • Adenosine Monophosphate / therapeutic use
  • Adenosine Triphosphate
  • Animals
  • Anti-Inflammatory Agents / therapeutic use
  • Antioxidants / pharmacology
  • Antioxidants / therapeutic use
  • Chitinase-3-Like Protein 1
  • Endotoxemia* / drug therapy
  • Endotoxemia* / pathology
  • Glutathione Reductase
  • Interleukin-10
  • Lipopolysaccharides
  • Lung / pathology
  • Matrix Metalloproteinase 2
  • Matrix Metalloproteinase 9
  • Matrix Metalloproteinases
  • Melatonin* / pharmacology
  • Melatonin* / therapeutic use
  • Phosphates
  • Phosphocreatine / therapeutic use
  • Rats
  • Superoxide Dismutase
  • Thiobarbituric Acid Reactive Substances
  • Tissue Inhibitor of Metalloproteinase-1
  • Tumor Necrosis Factor-alpha / therapeutic use

Substances

  • Anti-Inflammatory Agents
  • Antioxidants
  • Chitinase-3-Like Protein 1
  • Lipopolysaccharides
  • Phosphates
  • Thiobarbituric Acid Reactive Substances
  • Tissue Inhibitor of Metalloproteinase-1
  • Tumor Necrosis Factor-alpha
  • Phosphocreatine
  • Interleukin-10
  • Adenosine Monophosphate
  • Adenosine Triphosphate
  • Superoxide Dismutase
  • Glutathione Reductase
  • Matrix Metalloproteinases
  • Matrix Metalloproteinase 2
  • Matrix Metalloproteinase 9
  • Melatonin
  • Adenosine